GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW) | ||||||
---|---|---|---|---|---|---|
|
07:01 Apr 27, 2022 |
French to German translations [PRO] Medical - Medical: Pharmaceuticals / Angiotensin-II-Rezeptor-Antagonist | |||||
---|---|---|---|---|---|
|
| ||||
| Selected response from: Steffen Walter Germany Local time: 11:19 | ||||
Grading comment
|
Summary of answers provided | ||||
---|---|---|---|---|
3 +2 | (sogenannte) „LIFE“-Indikation |
|
Summary of reference entries provided | |||
---|---|---|---|
LIFE-Studie? |
|
Discussion entries: 1 | |
---|---|
(sogenannte) „LIFE“-Indikation Explanation: Siehe Referenzbeitrag und z. B. https://www.medikamente-per-klick.de/images/ecommerce/09/19/... ("Losartan-CT 12,5 mg vermindert das Risiko eines Schlaganfalls (sog. „LIFE“-Indikation)"). |
| ||||||||||||
Grading comment
| |||||||||||||
|
9 mins peer agreement (net): +1 |
Reference: LIFE-Studie? Reference information: Könnte sich das auf die Ergebnisse der LIFE-Studie bzw. eine daraus abgeleitete Indikation beziehen (ich nehme an, es geht um Losartan)? Siehe dazu https://www.medicines.org.uk/emc/product/5961/smpc "LIFE-study The Losartan Intervention For Endpoint Reduction in Hypertension [LIFE] study was a randomised, triple-blind, active-controlled study in 9193 hypertensive patients aged 55 to 80 years with ECG documented left-ventricular hypertrophy. ... Treatment with losartan reduced the risk of stroke by 25% relative to atenolol (p=0.001 95% confidence interval 0.63-0.89)." Auch in deinem Text wird ja neben der arteriellen Hypertonie die linksventrikuläre Hypertrophie erwähnt, zudem die Reduzierung des Risikos eines Schlaganfalls. |
| |
Login to enter a peer comment (or grade) |
Login or register (free and only takes a few minutes) to participate in this question.
You will also have access to many other tools and opportunities designed for those who have language-related jobs (or are passionate about them). Participation is free and the site has a strict confidentiality policy.